Obesity: a main factor of metabolic syndrome?

被引:0
作者
Licata, G. [1 ]
Argano, C. [1 ]
Di Chiara, T. [1 ]
Parrinello, G. [1 ]
Scaglione, R. [1 ]
机构
[1] Univ Palermo, Dept Internal Med, I-90133 Palermo, Italy
关键词
obesity; insulin resistance; metabolic syndrome; cardiovascular diseasess;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The metabolic syndrome (NIS) is a common metabolic disorder that has been recently related to the increasing prevalence of obesity. The disorder is defined in various ways, but in the near future a new definition(s) will be applicable worldwide. The pathophysiology has been largely attributed, in the past years, to insulin-resistance, even if several epidemiological and pathophysiological data are attractive to indicate visceral obesity as a main factor in the occurrence of the NIS, promoting new definitions and re-evaluation of the pathogenesis of this syndrome. In this review, we have analyzed the role of visceral obesity in the new definition of the NIS such as the pathophysiological role of the abnormal fat distribution in the occurrence of this syndrome. In view of this, relationships between visceral obesity, free fatty acids, dyslipidaemia and insulin-resistance have been reported. In addition, the effects of some adipocytokines and other proinflammatory factors produced by fat accumulation on the appearance of the NIS have been also emphasized. Finally, according to recommendations of several international societies, the role of the life-style change and of the weight loss in the prevention and treatment both of obesity and of other associated risk factors has been analyzed.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 44 条
  • [1] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [2] A common amino acid polymorphism in insulin receptor substrate-1 causes impaired insulin signaling - Evidence from transfection studies
    Almind, K
    Inoue, G
    Pedersen, O
    Kahn, CR
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11) : 2569 - 2575
  • [3] Anderson LL, 1999, CURR CLIN ONCOL, V1, P87
  • [4] Avogaro P, 1965, DIABETOLOGIA, V1, P137
  • [5] Balkau B, 1999, DIABETIC MED, V16, P442
  • [6] Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
  • [7] Adiposopathy: sick fat causes high blood sugar, high blood pressure and dyslipidemia
    Bays, Harold
    Abate, Nicola
    Chandalia, Manisha
    [J]. FUTURE CARDIOLOGY, 2005, 1 (01) : 39 - 59
  • [8] INCREASED APO-A-I AND APO-A-II FRACTIONAL CATABOLIC RATE IN PATIENTS WITH LOW HIGH-DENSITY LIPOPROTEIN-CHOLESTEROL LEVELS WITH OR WITHOUT HYPERTRIGLYCERIDEMIA
    BRINTON, EA
    EISENBERG, S
    BRESLOW, JL
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (02) : 536 - 544
  • [9] Body-mass index and mortality in a prospective cohort of US adults
    Calle, EE
    Thun, MJ
    Petrelli, JM
    Rodriguez, C
    Heath, CW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1999, 341 (15) : 1097 - 1105
  • [10] Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
    Cleeman, JI
    Grundy, SM
    Becker, D
    Clark, LT
    Cooper, RS
    Denke, MA
    Howard, WJ
    Hunninghake, DB
    Illingworth, DR
    Luepker, RV
    McBride, P
    McKenney, JM
    Pasternak, RC
    Stone, NJ
    Van Horn, L
    Brewer, HB
    Ernst, ND
    Gordon, D
    Levy, D
    Rifkind, B
    Rossouw, JE
    Savage, P
    Haffner, SM
    Orloff, DG
    Proschan, MA
    Schwartz, JS
    Sempos, CT
    Shero, ST
    Murray, EZ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19): : 2486 - 2497